Explore the words cloud of the AD Detect-Prevent project. It provides you a very rough idea of what is the project "AD Detect-Prevent" about.
The following table provides information about the project.
|Coordinator Country||Denmark [DK]|
|Total cost||3˙880˙990 €|
|EC max contribution||2˙936˙546 € (76%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2018-11-01 to 2020-10-31|
Take a look of project's partnership.
|1||BRAIN+ APS||DK (KOBENHAVN)||coordinator||2˙203˙703.00|
|2||AARHUS UNIVERSITET||DK (AARHUS C)||participant||454˙669.00|
|3||THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD||UK (OXFORD)||participant||184˙923.00|
|4||ALZHEIMER EUROPE||LU (LUXEMBOURG)||participant||68˙250.00|
|5||THE EUROPEAN BRAIN COUNCIL AISBL||BE (BRUXELLES)||participant||25˙000.00|
Alzheimer’s disease (AD) is central to the rapidly growing and crushing ageing challenge that threatens to economically undermine today’s health care system. AD prevalence will grow to over 100m cases in 2050. AD is incurable, but can be prevented. Detecting pre-symptomatic signs of AD in at-risk groups and intervening early may be the only viable solution. Our target is to bring to market a novel ICT tool, named ‘AD Shield’, that screens for and detects pre-symptomatic stage cognitive decline related to AD, and creates a personalized program for each individual user to strengthen weakened cognitive abilities, thus building cognitive reserve and reducing AD risk. Brain will collaborate with world leading neuroscientists to validate this ICT tool. Completion of the tasks described in the workplan will secure the remaining development adaptation combination and validation of the existing technological breakthroughs of the Brain method and ICT platform, including the Oxford University’s new highly sensitive cognitive assessment method. The end product will be a scientifically validated, effective, economic, engaging and easily accessible method for pre-symptomatic detection of AD and preventative training. 'AD Shield' can be value created and costs saved of up to €60.000 per patient for the healthcare payers, and at EU level saving can amount to €7bn-108bn direct costs per year and €155bn informal care costs per year. Success stemmed from this phase 2 project will also empower AD at-risk groups and allow them to stay active in the labour market for longer. The combination of costs saved will ultimately boost EU competitiveness.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "AD DETECT-PREVENT" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "AD DETECT-PREVENT" are provided by the European Opendata Portal: CORDIS opendata.